NASDAQ: CDXS · Industrial Applications and Services · 4 alerts · CIK 1200375
Share price
$1.06Close, Nov 16
Market cap
$116M
Shares outstanding
109.6MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Industrial Organic ChemicalsSIC 2860
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Codexis, Inc. filings on SEC EDGAR ↗
Codexis reported strong Q3 2026 revenue growth driven by biocatalysis and significant technical milestones in its Ecosynthesis platform, including 100-gram scale production and improved potency.
Codexis reported a significant increase in total revenues to $19.26 million for Q3 2026, up from $8.60 million in the prior year, driven primarily by product revenue growth. The company successfully reduced its quarterly net loss to $8.13 million compared to $19.62 million in Q3 2025, while strengthening its cash position through a $24.9 million net equity offering.
Codexis reported Q3 2026 revenue of $19.3 million, a significant increase from $8.6 million in the prior year, driven by higher product revenue from new customer launches. The company also highlighted a new $60 million term loan facility with Trinity Capital and the successful scale-up of its ECO Synthesis Manufacturing Platform to 100-gram scale.
Term
Q3 2026
“I am pleased with our outstanding progress in 2026, through both innovation and technical achievements, that has garnered attention from leading innovators in the siRNA field.”
Alison Moore, PhD, President and Chief Executive Officer
“We have made significant progress in industrializing our technology while simultaneously increasing our revenue base, managing expenses, and improving the financial stability of our company.”
Alison Moore, PhD, President and Chief Executive Officer
Codexis $60M Debt Financing with Trinity Capital Inc.
Codexis entered into a $60 million Loan and Security Agreement with Trinity Capital, consisting of a $42.5 million initial tranche and $17.5 million in subsequent tranches. The debt is secured by substantially all company assets and carries a variable interest rate with an interest-only period extending up to November 2030. The facility provides capital to support operations while maintaining a financial covenant tied to the company's market capitalization.